Zhejiang Huahai Pharmaceutical Co.,Ltd.’s Net Profit Rose 20.5% in First Quarter of 2023
Listen to the full version

Zhejiang Huahai Pharmaceutical Co.,Ltd. (浙江华海药业股份有限公司) (600521.SH) reported a net profit of 168.5 million yuan in the first quarter of 2023, up 20.5% year-on-year.
Meanwhile, the company posted 2.1 billion yuan in revenue, up 16.2% year-on-year.
At the end of the reporting period, it had 18.7 billion yuan in total assets and 10.8 billion yuan in total liabilities, with a liability-to-asset ratio of 57.6%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR